PMID33257658 (S2):
  drug: olaparib
  cell-lines: HeLa
  type: Post-perturbation
  modality: CRISPR/Cas9 knockout
  resource: Suppl. Table 2
  filter: FDR < 0.01
  signature:
  - COX17
  - MARS2
  - VHL
  - C14orf80
  - RPP21
  - POLR3H
  - ATP6V1B2
  - PSMG3
  - TELO2
  - IPO13
  - ZBTB8OS
  - CYCS
  - POLG2
  - ATP6V0C
  - GINS2
  - RPL28
  - PRMT1
  - TIPARP
  - WDR77
  - SYS1
  - RPE
  - NHP2
  - GFER
  - VRK1
  - SPATA5L1
  - MYH9
  - MAK16
  - CDIPT
  - CHURC1-FNTB
  - WDR83
  - E2F7
  - NOL10
  - WDR18
  - HSD17B10
  - GPN2
  - CEBPZ
  - RPLP0
  - PGP
  - RPL24
  - TUFM
  - MRPL57
  - ATP6V1G1
  - CYC1
  - GART
  - UQCRC1
  - ATP6AP1
  - DPH1
  - PGAM1
  - NUPL1
  - NEDD8
  - CIAO1
  - SKP2
  - DNM1L
  - PRMT5
  - TPI1
  - ARPC4
PMID33257658 (S1):
  drug: olaparib
  cell-lines: HeLa
  type: Baseline
  modality: CRISPR/Cas9 knockout
  resource: Suppl. Table 1
  filter: pval < 0.01
  signature:
  - RNASEH2B
  - XRCC1
  - CHTF8
  - XRCC3
  - RAD51C
  - C4orf27
  - CASC1
  - RNASEH2C
  - RNASEH2A
  - CTGF
  - CCS
  - KIZ
  - MRE11A
  - FLG
  - HDDC2
  - POLE4
  - RNF125
  - FANCE
  - C17orf70
  - LRRC63
  - LIG1
  - CASD1
  - PPIAL4F
  - RIF1
  - GCG
  - ZNF662
  - FGD3
  - ITPA
  - SIGLEC8
  - FABP1
  - NBN
  - OR6C1
  - RAD54L
  - SYT4
  - ZNF106
  - SMCR8
  - C19orf40
  - CKS1B
  - MELK
  - ITLN2
  - CLMP
  - SWI5
  - ANKRD24
  - RAD51B
  - RASSF10
  - G3BP1
  - ACSF2
  - SCAI
  - TCF24
  - MVB12A
  - ERCC6
  - MUS81
  - ANKRD62
  - DDX24
  - YAP1
  - PCDH8
  - MAPK9
  - AGMO
  - PVRL1
  - OSBPL9
  - ZNF91
  - CHD1L
  - STARD3
  - DNAJC9
  - RAD1
  - RGS20
  - POLE3
  - C20orf173
  - RAD51
  - PAWR
  - ASIC1
  - PARP10
  - FIBIN
  - IHH
  - APEX2
  - PGP
  - AQP10
  - PTH2
  - FANCA
  - CCNF
  - ANKRD39
  - SLC35F4
  - ZDHHC20
  - IER3
  - FOXI2
  - NEK1
  - SIRT7
  - C7orf62
  - PSMC3IP
  - PSIP1
  - MAU2
  - POLR2B
  - SLC10A6
  - STAC3
  - HIST1H2AE
  - KLHDC3
  - PTDSS1
  - RAD54B
  - PLEKHM3
  - SLC7A6
  - ZNF223
  - HSFY1
  - FAM9B
  - PCDHGB2
  - PRPS1
  - CEACAM16
  - GAS1
  - DUSP9
  - UFSP2
  - PSG3
  - CECR6
  - KRTAP4-4
  - NUP37
  - EVPLL
  - ZNF337
  - ANO9
  - DHX37
  - ANKRD18A
  - CNPY3
  - UFSP1
  - C9orf116
  - CENPE
  - ATP13A1
  - LIPE
  - SLC4A2
  - LHCGR
  - SGCA
  - YES1
  - ATM
  - GPC6
  - VWA8
  - GABPA
  - MED15
  - POLB
  - B4GALNT4
  - FAM26E
  - CLIC3
  - TMEM8B
  - SCFD2
  - ARHGEF28
  - KLHL36
  - ERV3-1
  - ADAT1
  - BARX1
  - TMEM198
  - RPGR
  - AMN1
  - NMRK2
  - NLRX1
  - REXO1
  - SMAD5
  - FAM171B
  - CD74
  - ZGLP1
  - TSR2
  - KRTAP4-11
  - KANK3
  - ANGPTL6
  - C8B
  - DSC2
  - TIMM21
  - NIPSNAP1
  - COMMD3
  - PCMTD1
  - TTLL10
  - MAP2K2
  - TAS2R14
  - SCN5A
  - BMPR2
  - C4orf51
  - WDR38
  - XCL2
  - ALDH7A1
  - CELA1
  - C21orf91
  - GPR162
  - TMEM115
  - LRRC7
  - KAT2B
  - C2orf40
  - OR9G1
  - CNNM1
  - FAM98A
  - KPRP
  - CEP135
  - RPS20
  - LCE1B
  - NAT8
  - TMPRSS11A
  - SH2D1A
  - NODAL
  - CLCC1
  - ACLY
  - LCE1E
  - UBE2D4
  - ECHS1
  - SHISA5
  - IER5L
  - USP29
  - ZC2HC1B
  - LUZP1
  - ACTG1
  - EXD1
  - CARKD
  - RABGEF1
  - SLC2A4RG
  - P2RX3
  - RASEF
  - PTCRA
  - MSL3
  - WDR53
  - PUM1
  - KIAA1841
  - TCTN3
  - TM7SF2
  - RAD17
  - TOMM70A
  - LZTS2
  - NMNAT1
  - SERP2  
PMID33665980:
  type: Prior-based
  modality: PCR
  resource: Methods
  signature:
  - ACVR1B
  - CDH1
  - EXOC2
  - ITCH
  - NCOR1
  - PTEN
  - WEE1
  - AKT1
  - CDKN2A
  - EXT2
  - KMT2C
  - NEK2
  - PTGFR
  - ZBED4
  - ATM
  - EGFR
  - FBXO32
  - MAP2K4
  - PBRM1
  - RB1
  - BAP1
  - EP300
  - FGFR1
  - MAP3K1
  - PCGF2
  - RET
  - BRCA1
  - ERBB2
  - FGFR2
  - MDM2
  - PIK3CA
  - SEPT9
  - BRCA2
  - ERBB3
  - GATA3
  - MUC16
  - PIK3R1
  - TP53
  - CBFB
  - ESR1
  - IRAK4
  - MYC
  - PPM1L
  - TRAF5  
PMID27048245:
  drug: alpelisib
  cell-lines: MCF-7, T47D
  type: Post-perturbation
  modality: Mass Spec
  resource: Add. files 2/3
  filter: abs(logFC) > 2
  signature:
  - ANKS1A
  - BCAR1
  - CTTN
  - EEF1A2
  - EPHA1
  - FAM83F
  - FGB
  - G6PD
  - GPRC5C
  - HIST1H4A
  - HSP90AA1
  - MAPK13
  - MDH2
  - MYO1D
  - PIK3R1
  - PLEKHA6
  - PTK2
  - SRCIN1
  - TJP2  
PMID32286420:
  drug: everolimus
  cell-lines: CAL-51
  type: Post-perturbation
  modality: Taqman low density arrays
  resource: Figure 4
  signature:
  - CCNB1
  - CHEK1
  - CCNE1
  - CHEK2
  - FOS
  - PARP2
  - ABCB1
  - MAPK3
  - E2F1
  - ERBB3
  - CDK2
  - CDKN1A
  - BRCA1
  - CCNA1
  - CDK4
  - CASP3
  - ABCG2
  - RAPR1
PMID16288014:
  drug: etoposide
  cell-lines: HCC1937, T47D
  type: Baseline
  modality: Gene Expr. Microarray
  resource: Suppl. Data
  signature:
  - ABCC5
  - ACE2
  - ACTN1
  - AGPS
  - AKR1B10
  - AKR1C3
  - ALCAM
  - ALDH3A1
  - ALDH3B2
  - ALPP
  - ANK3
  - ANXA10
  - AP3S1
  - APG-1
  - APOBEC3A
  - ASPM
  - ATP5I
  - B7-H4
  - BIGM103
  - BPAG1
  - C14orf139
  - C14orf143
  - C1R
  - C1S
  - CALB1
  - CAV1
  - CAV2
  - CCL26
  - CDKN2C
  - CEACAM1
  - CEACAM5
  - CEACAM6
  - COL12A1
  - CPM
  - CRSP2
  - CTBP1
  - CTSB
  - CTSC
  - CTSS
  - CXCL11
  - DEFB1
  - DHRS2
  - DIO2
  - DKK1
  - DNER
  - DREV1
  - DSCR6
  - DUSP7
  - EDG2
  - EDG3
  - EEF1A1
  - EEF1A2
  - ELL2
  - EPSTI1
  - ESDN
  - FADS1
  - FADS3
  - FARP1
  - FHL1
  - FLJ11151
  - FLJ12688
  - FLJ20152
  - FLJ20333
  - FLJ31166
  - FLJ32115
  - FLJ32798
  - FLJ34233
  - FLJ38725
  - FLJ90036
  - FOXP1
  - GALNT12
  - GALNT5
  - GBP1
  - GBP2
  - GDA
  - GNE
  - GPR110
  - GPR87
  - GSK3B
  - HAS3
  - HHGP
  - HIC
  - HNRPD
  - HPGD
  - HRB
  - HS6ST2
  - IGFBP2
  - IL1RL1
  - IRF6
  - ITGA2
  - JAG1
  - JDP2
  - KDELR3
  - KIAA0303
  - KIAA0746
  - KIAA1223
  - KLHL5
  - KLK8
  - KRT15
  - KRT17
  - LGN
  - LMO4
  - LOC285463
  - LOC51123
  - LPHN2
  - LPP
  - LTB
  - MAL
  - MAOA
  - MAP2K1IP1
  - MATN2
  - MFI2
  - MGAT4A
  - MGC19764
  - MGC22679
  - MGC39518
  - MOCS2
  - MRS2L
  - MUC1
  - N33
  - NAV3
  - NMU
  - NT5E
  - NUPL1
  - OACT1
  - P4HA2
  - PAK2
  - PAK6
  - PAM
  - PAX6
  - PCOLCE2
  - PCYT1A
  - PDZK3
  - PHGDH
  - PIK3CD
  - PLAC1
  - PLAT
  - PLCB4
  - PPP1R2
  - PRKACB
  - PRKCL2
  - PRNP
  - PRO2000
  - PSCA
  - PTGS2
  - PTX3
  - PVRL2
  - RAB4A
  - RARRES3
  - RASGRP1
  - RBM15
  - RBM6
  - RFC3
  - RGS20
  - RHBDL2
  - RHOBTB3
  - RNF3
  - S100A2
  - S100A4
  - S100A7
  - S100A8
  - S100A9
  - SAA2
  - SART2
  - SCD4
  - SCEL
  - SDC1
  - SDC1
  - CD138
  - SYND1
  - SDCCAG8
  - SELT
  - SERPINA3
  - SERPINB2
  - SERPINE1
  - SFN
  - SFRP1
  - SFRS11
  - SLC9A1
  - SMAP
  - SMBP
  - SOD2
  - SORL1
  - SPUVE
  - ST7
  - SULF2
  - TAGLN
  - TFAP2A
  - TGFB1
  - TM4SF1
  - TP73L
  - TRIM31
  - TSPAN-1
  - TSPAN-2
  - UCC1
  - VAV3
  - VEGFC
  - WSB1
  - XPOT
  - ZDHHC11
  - ZNF399
  - FLJ13153
PMID30867218:
  drug: palbociclib
  cell-lines: MCF-7, T47D
  type: Post-perturbation
  modality: RNAseq
  resource: Suppl. Table 3
  filter: abs(logFC) > 2, padj < 0.01
  signature:
  - PKIA
  - PMP22
  - MAGEA3/MAGEA6
  - MAGEA12
  - ANGPT1
  - CSAG1
  - ZC2HC1A
  - DSCAM-AS1
  - IL7
  - BCHE
  - KCNK2
  - NR2F1
  - FZD6
  - MAGEA3/MAGEA6
  - DMD
  - VCX2 (includes others)
  - SATB1-AS1
  - FAM198A
  - NDST4
  - CBLN2
  - CLDN1
  - CLEC2B
  - RBM20
  - GABRA3
  - EPHA4
  - RIMS1
  - VCX/VCX3A
  - DRD2
  - EPHA6
  - MAGEA10
  - PTGES
  - KYNU
  - RTN1
  - FGFBP2
  - KCNS3
  - SATB1
  - GHR
  - GAS6
  - NTNG1
  - RAP2C
  - WFIKKN2
  - NR2F1-AS1
  - DIO1
  - LOC101927003
  - NMU
  - ARHGEF6
  - PCED1B
  - GJA1
  - KLHL13
  - WDR72
  - CD302
  - TENM3
  - GABRE
  - ST8SIA1
  - CYP4F35P
  - SLITRK5
  - NSDHL
  - CUX2
  - KLF12
  - SCD
  - RIPK3
  - ZDHHC2
  - GAS6-AS1
  - CKMT2
  - C5orf49
  - CALCR
  - RTBDN
  - TNS1
  - RGAG4
  - C10orf82
  - SMCO3
  - HSD11B2
  - TNFRSF14
  - ZFR2
  - KIF26A
  - CRYAB
  - IRF1
  - TNFRSF11A
  - LTBP2
  - PIGR
  - SHC2
  - JUNB
  - NAV2
  - LAMP3
  - TNF
  - AOC2
  - HCG4P11
  - STAT5A
  - DDX58
  - CDK6
  - APOL1
  - RGS16
  - TNXB
  - OSBPL7
  - TGFBR3
  - CD44
  - CCL20
  - ADORA1
  - JUN
  - ADAMTS10
  - CXCL10
  - SRGAP3
  - CDC42EP3
  - BDKRB2
  - HLA-A
  - NFKBIA
  - TMEM173
  - KRT13
  - FYN
  - ANGPTL6
  - ETV7
  - RDH16
  - APOL6
  - STEAP2
  - WNT4
  - PDGFD
  - C19orf66
  - TMC5
  - BATF2
  - IFIT5
  - SAT1
  - EVC
  - GREM2
  - HERC6
  - LTB
  - ADCY1
  - PPP1R1B
  - ADGRB1
  - GBP2
  - PPP1R14C
  - PAMR1
  - TNFSF15
  - OAS3
  - TMEM179
  - LRRN2
  - CIB2
  - OASL
  - STRA6
  - EMB
  - BTG2
  - DSCAML1
  - TNFAIP2
  - COL16A1
  - JPH2
  - DAPP1
  - LINC00304
  - BOC
  - DTX4
  - LMO2
  - CPNE7
  - KIF12
  - ADRB1
  - PLEKHS1
  - REC8
  - TNFAIP3
  - BEND7
  - RAI2
  - KLF4
  - CAMK2B
  - PLXNA2
  - HCP5
  - ZC4H2
  - PDZD4
  - PI3
  - CHN1
  - HELZ2
  - PHLDB2
  - NABP1
  - GBP1
  - DDX60L
  - OAS2
  - ZNF618
  - ICAM1
  - PTP4A3
  - NKD2
  - ST3GAL5
  - LGALS3BP
  - S100A9
  - SCGB2A2
  - HLA-DPB1
  - CCL28
  - PSG9
  - PTCHD1
  - ABCC3
  - SAMD9
  - ATAD3C
  - CFB
  - IRF9
  - DDX60
  - SPRY4
  - CYP4Z1
  - CD34
  - C6orf141
  - PLEKHH2
  - LINGO1
  - IFIT1
  - CREB3L1
  - ITGAM
  - C3
  - LIF
  - IGFBP3
  - LINC00648
  - FOS
  - SLPI
  - SAMD9L
  - CMPK2
  - PDE9A
  - SAA2
  - TIMP3
  - CRYM
  - SLC44A5
  - SPINK5
  - SAA1
  - NTN4
  - IFITM3
  - PDZK1
  - MX1
  - CRISP3
  - IFIT3
  - WNT5A
  - HLA-DPA1
  - ARSJ
  - COL27A1
  - IFIT2
  - LGALS9
  - C15orf59
  - LINC00867
  - DKK1
  - HLA-DQA1
  - BIRC3
  - ISG15
  - OAS1
  - C14orf132
  - LCN2
  - XAF1
  - MDGA1
  - S100A8
  - IFI6
  - CYP1A1
  - GLYATL3
  - FMOD
  - CD74
  - GALNT5
  - RSAD2
  - CXCL13
  - IFI44L
  - HLA-DRA
  - HEPHL1
  - IFI44
  - CLEC3A
  - IFI27
PMID28249908:
  drug: ribociclib
  cell-lines: MCF-7
  type: Baseline
  modality: siRNA
  resource: Table 1
  signature:
  - PDK1
  - DLG1
  - DCAMKL1
  - CDKN1B
  - DYRK1A
  - HUNK
  - ILK
  - YES1
  - CRKL
  - TLK1
  - KCNH8
  - EPHA4
  - EPHB1
  - RELA
  - ICK
PMID20423993:
  drug: dasatinib
  cell-lines: 23 cell lines
  type: Baseline
  modality: Microarray
  resource: Suppl. Table 2
  signature:
  - DNAJB12
  - JAG1
  - PKM2
  - SLC2A8
  - PIM1
  - PTRF
  - KREMEN2
  - MGC4278
  - SSR1
  - IFI16
  - CA12
  - HLF
  - AKR1C3
  - FLJ11773
  - ABCA3
  - RTEL1
  - PCDH7
  - PINK1
  - RPRC1
  - FXYD5
  - HK1
  - TAX1BP3
  - MAPT
  - TNFRSF21
  - LAMC1
  - F2RL1
  - ELL2
  - VAMP3
  - TSFM
  - LEPREL1
  - C21orf5
  - EPHB2
  - MAP4K4
  - SNAI2
  - CAV1
  - MGC5242
  - PSMB9
  - ZNF24
  - FLJ13197
  - RGS2
  - TBC1D5
  - CAST
  - PIGH
  - SLC35A1
  - TGFBR2
  - AKT2
  - TARS
  - HNRPUL2
  - APOL3
  - LRRC50
  - GDF11
  - ICA1
  - CLN3
  - ARID4A
  - MDM2
  - ABCG1
  - CAV2
  - ANXA2P3
  - CTNND2
  - EPHA2
  - PTK7
  - UBE2E3
  - MYCN
  - PSMB8
  - STRN3
  - SEL1L
  - IFIT3
  - MFN2
  - OSMR
  - CORO1B
  - PDGFC
  - BTN3A3
  - ARF7
  - TRAP1
  - SMPX
  - CBX2
  - ATP10D
  - SMAD3
  - M-RIP
  - UPP1
  - DPYD
  - MSN
  - RIN3
  - KIAA0984
  - ELK3
  - CROP
  - NDUFAB1
  - LUZP1
  - PDCD4
  - NSUN5
  - PSD
  - JRKL
  - RSAD1
  - RBM9
  - FLJ21148
  - FLJ10211
  - CLDN3
  - PLCB4
  - GNG12
  - ANXA2
  - KIAA1324
  - WDR39
  - NDUFC1
  - ARHGAP29
  - ANXA2P2
  - TFF1
  - ACSL3
  - CD44
  - ZPBP
  - C6orf108
  - PLXNA3
  - FSTL1
  - NDUFS3
  - DKFZp667G2110
  - ZDHHC24
  - SAMD9
  - KIAA1040
  - DST
  - C14orf124
  - C6orf96
  - ZNF646
  - EXTL1
  - CASP10
PMID22617229:
  drug: dasatinib
  cell-lines: BT-20, BT-549, MDA-MB-468, MDA-MB-231, MCF7, HCC1937
  type: Baseline
  modality: Mass Spec
  resource: Table 2
  signature:
  - ITGB4
  - BAIAP2
  - GPCR5A
  - ITPR3
  - TNKS1BP1
  - ARHGEF18
  - IASPP
  - APG16L
  - TPD52L2
PMID27450721:
  drug: bleomycin
  type: Prior-based
  modality: Radioresistance
  resource: Table S1
  signature:
  - ABCC4
  - ABCG2
  - AKT1
  - APEX1
  - ATM
  - ATR
  - AURKA
  - BABAM1
  - BAX
  - BBC3
  - BCL2
  - BCL2L1
  - BCL2L12
  - BECN1
  - BIRC5
  - BNIP3
  - BRCA1
  - CDK5RAP3
  - CDKN1A
  - CHEK1
  - CHEK2
  - CLU
  - DCLRE1C
  - DDB2
  - EGFR
  - EIF2AK3
  - ERCC1
  - ERCC4
  - ERCC6
  - ERP29
  - FANCD2
  - FANCG
  - GAGE7
  - GCLM
  - HIF1A
  - HLTF
  - HSPB1
  - HUWE1
  - ICAM3
  - INPP4B
  - ITGB1
  - KEAP1
  - MADD
  - MCL1
  - MDC1
  - MGMT
  - MIR21
  - MIR31
  - MRE11A
  - MVP
  - NFE2L2
  - NFKB1
  - NOL3
  - POLH
  - PRKDC
  - RAD18
  - RAD51
  - RAD52
  - RAD54L
  - RALBP1
  - REG4
  - RNF168
  - RNF8
  - STAT3
  - TIGAR
  - TIP1
  - TLK1
  - TP53
  - TP53BP1
  - TRIM29
  - TWIST1
  - UVRAG
  - XIAP
  - XPA
  - XRCC4
  - XRCC5
  - XRCC6
  - XRCC8
  - YBX1
PMID15318941:
  drug: docetaxel
  cell-lines: MCF-7, MDA-MB-231
  type: Post-perturbation
  modality: Gene Expression
  resource: Table 2
  signature:
  - ERBB2
  - CXCL8
  - FGF2
  - BIRC5
  - MAPK14
  - TNFRSF1A
  - BAX
  - CCNE1
  - TNFRSF10B
  - CDKN1B
PMID22500798:
  drug: AZD6244
  cell-lines: MDA-MB-231, SUM159
  type: Post-perturbation
  modality: Phospho Mass Spec
  resource: Table S6
  signature:
  - AAK1
  - TNK2
  - ACVR1
  - CDK1
  - CDK5
  - CDK6
  - CSK
  - CSNK2A2
  - DDR1
  - EGFR
  - EPHA2
  - EPHB4
  - GAK
  - CSNK1D
  - CAMK2D
  - CAMK2G
  - PRKD1
  - PRKD3
  - RPS6KA3
  - MAPK1
  - MAP2K2
  - NEK9
  - PDGFRB
  - PKMYT1
  - PRKDC
  - RIOK2
  - MST1
  - AURKA
  - TBK1
  - TTK
  - AXL
PMID25501949:
  type: Prior-based
  modality: Mutations
  resource: Table S1
  signature:
  - ABL1
  - AKT1
  - ALK
  - AURKA
  - AURKB
  - BCAT1
  - BRAF
  - BUB1B
  - CCND2
  - CCND3
  - CDK1
  - CDK2
  - CDK4
  - CDK6
  - KIT
  - CCND1
  - DHCR24
  - EGFR
  - FGFR1
  - FGFR2
  - FGFR3
  - GAB1
  - ERBB2
  - ERBB3
  - HRAS
  - IGF1R
  - IGF2
  - IKBKE
  - KRAS
  - LYN
  - MAP2K1
  - MET
  - MTDH
  - MYC
  - NF2
  - NOTCH1
  - NRAS
  - NTRK3
  - PIK3CA
  - PLK2
  - RAC2
  - RHOA
  - RHOC
  - RIT1
  - RPS6KB1
  - RUVBL1
  - STK11
  - VEGFA
  - YES1
PMID25865888:
  drug: lapatinib
  cell-lines: SKBR-3, BT474, HCC1419, HCC1954, MDA361
  type: Post-perturbation
  modality: Kinase / RNAseq
  resource: Suppl. Table 1
  signature:
  - PRKAA1
  - ABL1
  - AURKB
  - CDK1
  - CDK16
  - CDK17
  - CDK2
  - CDK4
  - CDK5
  - CHKB
  - CSK
  - CSNK2A2
  - DCK
  - DDR1
  - EGFR
  - EPHA2
  - EPHB3
  - EPHB4
  - PTK2
  - FRK
  - GSK3A
  - GSK3B
  - CHUK
  - IKBKB
  - INSR
  - JAK1
  - CSNK1A1
  - CAMK2G
  - PRKCD
  - PRKD3
  - RPS6KA1
  - RPS6KA3
  - RPS6KA6
  - RPS6KB1
  - LIMK1
  - MAP3K11
  - MAP3K2
  - MARK2
  - MAPK3
  - MAPK9
  - MAP3K20
  - NEK2
  - NEK9
  - PAK4
  - PDXK
  - PIP4K2B
  - PKMYT1
  - PRKDC
  - PTK6
  - RET
  - RIOK2
  - RIPK2
  - SIK2
  - SLK
  - STK16
  - STK3
  - AURKA
  - TGFBR1
  - TNK1
  - WEE1
  - YES1
PMID26771497:
  drug: 90 drugs
  cell-lines: 78 BRCA cell lines
  type: Prior-based
  modality: Gene Essentiality
  resource: Table S2A
  signature:
  - RPL23
  - RPS13
  - RPS26
  - RPL32
  - AQR
  - EIF3B
  - RPS14
  - RPL9
  - RPL11
  - HNRNPC
  - RPL36
  - POLR2D
  - RPS7
  - SF3B2
  - KPNB1
  - RPS19
  - COPB1
  - SNRPD2
  - EIF5B
  - ARCN1
  - RPL18
  - CDK11B
  - RPL5
  - RPS8
  - EEF2
  - PSMB2
  - TUBA1B
  - RAN
  - RPL10A
  - PSMA1
  - PRPF31
  - PRPF8
  - PSMD1
  - RPS15A
  - PSMA3
  - RPL23A
  - KARS
  - SNRPD1
  - RPS17
  - EIF3D
  - SF3B5
  - EIF3A
  - RPS27A
  - VCP
  - RPL7
  - SF3A1
  - U2AF1
  - RBM17
  - RPS11
  - RPL12
  - PRPF19
  - TUBA1C
  - SUPT5H
  - RPL37A
  - RPL4
  - EIF3C
  - RPL24
  - EFTUD2
  - SNRNP200
  - CCT3
  - CLTC
  - USP39
  - NUF2
  - RPLP0
  - PABPN1
  - RPSA
  - RPL3
  - RPL27
  - RPL31
  - RPL35
  - NUDT21
  - RPL7A
  - RPS6
  - RPS20
  - RPL19
  - SF3B1
  - RPS3
  - RPL34
  - EIF3I
  - NEDD8
  - RRM1
  - CCT8
  - SEM1
  - SFPQ
  - EIF2S2
  - POLR2I
  - COPZ1
  - CCT7
  - RPL35A
  - NXF1
  - DDX18
  - RPS18
  - PRPF38A
  - U2AF2
  - RFC4
  - HSPG2
  - EIF4A3
  - NUP205
  - RPS29
  - POLR2A
  - RPS3A
  - CDC5L
  - PSMC2
  - RPA2
  - SNRPG
  - CCNB3
  - SNU13
  - RPL13
  - NAPA
  - PAPOLA
  - RPL6
  - CDC40
  - ERH
  - SNRPE
  - EIF1AX
  - NUP93
  - RPL37
  - HSPA9
  - PSMC4
  - PSMD11
  - COPA
  - FTSJ3
  - PRPF3
  - EIF3G
  - EXOSC10
  - RPS9
  - PSMD6
  - CSE1L
  - ZNF207
  - EIF4E3
  - SF3B3
  - UBA1
  - RPA1
  - LSM5
  - HNRNPM
  - SPINT2
  - RPL14
  - RILPL2
  - LSM6
  - PHB
  - FUT9
  - PHF5A
  - GTF3C4
  - DYNC1I2
  - PSMB3
  - AURKB
  - DDX46
  - CHD4
  - DDX49
  - RUVBL2
  - MS4A13
  - PSMD7
  - LSM3
  - HNRNPU
  - WDR12
  - MPL
  - RPL30
  - FAM126A
  - SF3A2
  - DYNC1H1
  - INTS9
  - COPS2
  - PSMA6
  - SUPT6H
  - MCM2
  - ERCC6L
  - ADGRG4
  - CCT6A
  - NACA
  - POLA1
  - C12orf66
  - PHB2
  - NCOR2
  - DNM2
  - SNRNP27
  - RPL18A
  - PRPF18
  - TUBGCP2
  - TEKT2
  - NUP133
  - TLR9
  - IGFBP2
  - GREM1
  - RPL10
  - LSM4
  - SDAD1
  - SMC2
  - RPL17
  - CPSF1
  - NUP98
  - XPO1
  - EPHB4
  - PPP2R1A
  - RPLP2
  - EIF3F
  - SRCAP
  - RPS5
  - YY1
  - CDK17
  - MRPS31
  - ETF1
  - HSPE1
  - ZC3H13
  - PRUNE1
  - DAPK1
  - GNL3
  - RPS28
  - DDX51
  - RPS15
  - DDB1
  - POLR2F
  - RUVBL1
  - WDR61
  - PGLYRP4
  - CYP1A2
  - SKAP1
  - DUOXA2
  - ADCYAP1R1
  - ANAPC4
  - SRSF1
  - ALYREF
  - SCRG1
  - PSMD8
  - SRRT
  - PLK1
  - GPC6
  - TIE1
  - SNRNP70
  - ZC2HC1C
  - RAD51
  - ICK
  - PSMC3
  - UBB
  - DDR1
  - MDN1
  - TRPV6
  - CHEK1
  - RTF1
  - SEC61A1
  - RGS18
  - TSG101
  - RPTOR
  - BDKRB1
  - PSMB4
  - PSMD12
  - CEND1
  - MED30
  - ATP6V0D1
  - STAG2
  - RANBP2
  - PCBP2
  - DHX9
  - NR1D1
  - WBP11
  - INSR
  - MYO3B
  - RPLP1
  - ITGA2
  - TMOD3
  - PLRG1
  - POMGNT2
  - MTREX
  - RBMXL1
  - BUB1B
  - TM7SF2
  - IRS4
  - TIGD2
  - DDX41
  - FNDC7
  - TXK
  - RPS25
  - ECT2
  - ATP5MPL
  - NUDT4
  - LY96
  - CENPO
  - RGS13
  - RFTN1
  - NCBP1
  - RPRD1A
  - NUS1
  - NUP88
  - PTPN9
  - XBP1
  - PSMD3
  - MSANTD3
  - ZNF471
  - SMARCC1
  - DDR2
  - C16orf72
  - RBMX
  - TAF4B
  - ZNRF2
  - SMG1
  - TGFBR2
  - RPS12
  - SNAPC1
  - PJA2
  - SRSF3
  - TOPBP1
  - BMPR1A
  - SRSF2
  - GRPEL2
  - MTOR
  - CWC22
  - EIF3M
  - GEMIN5
  - NUP85
  - PARN
  - RINT1
  - NCAPG
  - SPAG7
  - ERBB3
  - MYBL2
  - AFG3L2
  - PPWD1
  - CEP192
  - ZNF174
  - PSMC5
  - ARHGAP29
  - TTC26
  - LUC7L3
  - SHMT1
  - ABCE1
  - TAF2
  - MRPS35
  - MRPL37
  - CLUL1
  - EIF6
  - USP1
  - TNKS1BP1
  - PUF60
  - IQGAP1
  - CCR6
  - CDK1
  - ERF
  - APOBEC3B
  - CCNG1
  - PPP5C
  - SLC12A2
  - KRAS
  - NAA38
  - SNX6
  - THBS1
  - SYMPK
  - ERBIN
  - PFKFB4
  - DNTTIP2
  - SEZ6L2
  - DDX21
  - KCTD6
  - MPP2
  - TBCD
  - ZNF155
  - FBXO9
  - TUBB
  - CARS2
  - COPB2
  - APOL2
  - CPSF3
  - NRP1
  - NUPL2
  - UBA6
  - STK3
  - PRKAG1
  - CDC37
  - CAPN2
  - CTSA
  - NDUFS7
  - APPL1
  - HKDC1
  - OR51E1
  - OR52L1
  - PIK3C2G
  - PRODH2
  - PODN
  - EVX1
  - PTPN22
  - KIR3DL2
  - SEMG2
  - RIPK3
  - RXFP1
  - PRDM12
  - KHDRBS2
  - GRM5
  - LDHC
  - SERPINA5
  - HP
  - PDE1B
PMID27378269:
  drug: tamoxifen
  cell-lines: 7 cell lines
  type: Post-perturbation
  modality: CNA / Mutations
  resource: Additional File 8
  signature:
  - TEX38
  - SPOCK3
  - TGFBR1
  - WASHC2A
  - CAMSAP3
  - RLIM
  - LCE4A
  - IGFN1
  - DNAH7
  - SP140L
  - CNTNAP5
  - MAST4
  - TAAR8
  - TRIM74
  - AKAP9
  - EEA1
  - TMEM132C
  - TRIM13
  - UNC13C
  - ZNF385D
  - DTX2
  - HAPLN3
  - DSPP
  - TIMM23
  - TMPRSS13
  - EP400
  - PTPRN2
  - TIMM23
  - TNS1
  - MAP2
  - PTH2R
  - NUTM2G
  - NHLRC2
  - PCF11
PMID27604488:
  drug: alpelisib
  cell-lines: T47D
  type: Baseline
  modality: RNAseq
  resource: Table S1
  signature:
  - NRG1
  - FGF3
  - FGF10
  - GPR161
  - TBC1D3G
  - RIC8A
  - DYRK1B
  - AXL
  - NMRK2
  - SRC
  - CDK5R1
  - PRKACA
  - PIM1
  - PIM3
  - PRKCZ
  - AKT1
  - PDK1
  - AKT2
  - CCND1
  - PPP1R3B
  - CRKL
  - CRB3
  - SRP54
  - YAP1
  - ZSCAN20
  - SMAD5
  - SAMD4B
  - B4GALT6
  - NUDT3
  - NUDT10
  - PIH1D3
  - MFSD5
  - C9orf24
  - C1QL2
  - PLEKHF1
  - GOLGA1
  - KCNIP1
  - PSMD13
  - PRAMEF9
  - USP38
  - SLC6A20
  - CMTM2
  - SLC51A
PMID29462756:
  drug: doxorubicin
  cell-lines: BT-549
  type: Post-perturbation
  modality: Mass Spec (Protein Quantification)
  resource: Table 2
  signature:
  - ANPEP
  - LRP1
  - DCLK1
  - COL5A1
  - OAS2
  - STEAP3
  - PLA2G4A
  - ITPR1
  - SERPINB5
  - DTX3L
  - EDIL3
  - ALDH5A1
  - MYO6
  - FHL2
  - CROT
  - LMCD1
  - GNG11
  - KYNU
  - CUX1
  - TAGLN
PMID30205045:
  drug: hormonal therapy
  cell-lines: patients
  type: Post-perturbation
  modality: Mutations
  resource: Figure 3
  signature:
  - ESR1
  - NF1
  - ERBB2
  - EGFR
  - ERBB3
  - KRAS
  - BRAF
  - MAP2K1
  - HRAS
  - MYC
  - FOXA1
  - CTCF
  - TBX3
PMID30305055:
  drug: lapatinib
  cell-lines: SKBR3
  type: Post-perturbation
  modality: Microarray
  resource: Suppl. Table 1
  signature:
  - APAF1
  - BCL2L1
  - BID
  - BAX
  - BBC3
  - BCL2L1
  - BNIP3L
  - CARD9
  - CASP1
  - CASP4
  - CFLAR
  - CRADD
  - HRK
  - MCL1
  - NLRP12
  - NFKBIB
  - RELB
  - RIPK2
  - TBK1
  - TNFRSF10A
  - TNFRSF1A
  - TNFRSF21
  - TNFRSF25
  - TNFSF10
PMID30914635:
  drug: ribociclib
  cell-lines: MCF-7
  type: Baseline
  modality: ORF kinome screen
  resource: Figure 1
  signature:
  - RAF1
  - CRKL
  - MAPK8
  - GRK6
  - SYK
  - TESK2
  - PRKAA2
  - CDK6
  - DYRK1B
  - MAP2K6
  - FGFR1
  - ROR2
  - FGR
  - NTRK1
  - FRK
  - HCK
PMID32344635:
  drug: palbociclib
  cell-lines: MCF7
  type: Post-perturbation
  modality: Gene Expression
  resource: Table 1
  signature:
  - DCN
  - GABRA3
  - LTF
  - CNGB1
  - SCGN
  - EPYC
  - FOLH1
  - CST4
  - MAP1LC3A
  - MSLN
  - EYA1
  - CRYAB
  - ADTRP
  - CNTN3
  - CCL20
  - DEFB126
  - GFAP
  - LUM
  - HDC
  - CYP39A1
PMID32753473:
  drug: trametinib
  cell-lines: SUM-229PE
  type: Post-perturbation
  modality: Gene Expression
  resource: Table S2D,F
  signature:
  - SOCS2
  - JAK2
  - JAK1
  - DUOX1
  - KMO
  - DUOX2
  - MELK
  - CDK2
  - CDK1
  - AURKB
  - AURKA
  - DNAH2
  - KIF14
  - KIF24
  - KIF23
  - KIF11
  - KIF22
  - SMC3
  - KIF15
  - CENPE
  - KIF18A
  - KIF18B
  - KIFC1
  - KIF4B
  - KIF4A
  - KIF2C
  - KIF21B
  - KIF20A
  - KIFC3
  - KIF20B
  - AOC3
  - MAOB
  - PDGFRB
  - COL3A1
  - COL1A2
  - DUSP4
  - DUSP7
  - IL15RA
  - IL1RL1
  - IL4R
  - IFNGR2
  - IL31RA
  - CD44
  - CMKLR1
  - IL12RB2
